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Abstract: To evaluate the progression of native lung fibrosis on thin-section computed tomography (CT) scans from 
patients with IPF after SLT, we retrospectively studied thin-section CT findings of the patients who survived more 
than 3 years. Three radiologists independently reviewed serial CT images from 12 patients who underwent SLT for 
IPF. Initial CT scans were performed up to 7 months before SLT or ≤12 months after SLT, and follow-up CT scan were 
performed >36 months after SLT. CT measurements of the total lung volume were performed on native lungs. CT 
scores were evaluated for native lung findings for each thin-section CT, including the fibrosis score (FS), ground-glass 
opacity score (GGS), and traction bronchiectasis score (TBS). Twelve patients survived 43-110 months after SLT. 
In the native lung, the FS and TBS values were positively correlated with time. Rates of increase in the FS and TBS 
values were 0.300/year and 0.147/year, respectively. The GGS showed a slight negative correlation with the lung 
volume from the CT reconstruction. Rates of decrease of the GGS and lung volume measurements were 0.307/year 
and 5.47%/year, respectively. The results show that despite more powerful immunosuppression, fibrosis of native 
lung continues to progress in patients who receive SLT for IPF.
Keywords: Lung transplant, idiopathic interstitial pneumonia, usual interstitial pneumonia, computed tomography, 
progression
Introduction
Idiopathic pulmonary fibrosis (IPF) is a chronic 
relentlessly progressive and fatal lung disease 
that leads to reduction in lung volumes and 
impaired gas exchange [1]. Patients with IPF 
have a poor prognosis; the mean life expectan-
cy from the time of diagnosis ranges 2.4-4.2 
years [2]. Clinical trials have been initiated 
recently to determine the effectiveness of alter-
native therapeutic agents for IPF; however, to 
date, no pharmacological therapy has been 
demonstrated to be effective for IPF [3]. 
Currently, the only long-term effective treat-
ment for IPF is lung transplantation. Patients 
who undergo lung transplantation have survival 
rates of only 50% at 5 years and 26% at 10 
years after transplantation [4].
Single lung transplantation (SLT) for patients 
with IPF provides a unique opportunity to study 
fibrosis in the native lung over time in a setting 
of pronounced immunosuppression. At our 
institution, lung transplant recipients are typi-
cally treated with a lifelong regimen of steroids, 
an antiproliferative agent (e.g., mycophenolate 
mofetil), and a calcineurin inhibitor (e.g., tacroli-
mus). Quantitative scoring methods are an 
acceptable modality for evaluating lung fibrosis 
progression on CT scans [5, 6]. However, few 
published reports describe the analysis of long-
term lung fibrosis from CT scans of the native 
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lung after SLT in patients with IPF [7-9]. 
Therefore, we performed a quantitative analy-
sis of lung volumes and fibrosis severity in 
sequential thin-section chest CT scans of 
patients who underwent SLT for IPF. The goal of 
this retrospective analysis was to determine 
whether the above combination of immunosup-
pressive agents could arrest the progression of 
fibrosis. Our study is the first to perform a direct 
quantitative analysis of CT scans for fibrosis 
progression and to examine the longitudinal 
outcomes of IPF patients after SLT.
Materials and methods
Patients
Among the 76 patients who underwent SLT for 
IPF at our center between Sep 1994 and Mar 
2008, sequential serial CT scans were avail-
able for 12 patients who, consequently, were 
included in this study. The CT scans of the 12 
patients were performed at our institution 
between Jan 2000 and Jan 2011. Clinical diag-
nosis of IPF at our institution is made on the 
basis of the following criteria: exclusion of 
other known causes of interstitial lung disease, 
characteristic abnormalities on thin-section CT 
scans (i.e., bibasilar subpleural honeycombing, 
thick interlobular septa, traction bronchiecta-
sis, and minimal ground-glass opacity [GGO]), 
and abnormal pulmonary function studies 
showing restriction and impaired gas exchange, 
according to the American Thoracic Society/
European Respiratory Society (ATS/ERS) con-
sensus classification criteria [10]. Pathological 
diagnosis of usual interstitial pneumonia was 
confirmed in the resected lung from all patients. 
Pulmonary function testing was performed in 
all patients within 3 months before lung trans- 
plantation.
All included patients had undergone at least 
two serial CT examinations; an initial CT scan 
was performed up to 7 months before or within 
12 months after SLT, and follow-up CT scans 
were performed >36 months after SLT. Patients 
without a suitable preliminary CT scan or follow-
up CT scan within 3 years after SLT were 
excluded.
The post-SLT immunosuppression regimen was 
a standard three-drug regimen consisting of 
tacrolimus, mycophenolate mofetil, and predni-
sone in all patients. Azathioprine, N-acetylcy- 
steine, and gamma-interferon were added in 
some patients.
CT technique
Over the time course of this retrospective 
series, CT scans were performed on various 
hardware, including Lightspeed CT scanners 
(Lightspeed QX/i, Ultra, and VCT models; GE 
Healthcare, Milwaukee, WI, USA). CT images 
were obtained with a section thickness of 
1.25-2.5 mm, interval of 10 mm during full 
inspiration, reconstruction matrix of 512*512, 
high-spatial-frequency reconstruction algori- 
thm, tube voltage of 120-140 kV, and tube cur-
rent-time product of 150-210 mAs, with or with-
out injection of contrast material. CT images 
were evaluated by using a lung window, with a 
window level of -500 HU and window width of 
1,500 HU. The soft-tissue window was not 
evaluated.
Image interpretation and thin-section CT scor-
ing
All thin-section CT images were reviewed by 
three radiologists. The reviewers were aware of 
the diagnosis of IPF. Pre- and post-transplanta-
tion scans were reviewed without blinding to 
laterality of the native lung. For the analysis 
of all scans, readers were blinded to the names 
of patients and the length of time since trans- 
plantation.
To evaluate the native lung, we choose four 
sections from each patient’s scan at the levels 
of the arterial arch, tracheal carina, inferior pul-
monary vein, and 1 cm inferior to the dia-
phragm. On each section, the native lung was 
scored separately on a scale from 0 to 5 for the 
presence of fibrosis and GGO. A previously 
described fibrosis scoring system that inte-
grates the severity of honeycombing and reticu-
lar opacities was used to evaluate the thin-sec-
tion CT images [11]. The fibrosis score (FS) was 
determined as follows: 0, no interstitial dis-
ease; 1, interlobular septal thickening, no dis-
crete honeycombing; 2, honeycombing (with or 
without septal thickening) involving ≤25% of 
the lobe; 3, honeycombing (with or without sep-
tal thickening) involving 25-49% of the lobe; 4, 
honeycombing (with or without septal thicken-
ing) involving 50-75% of the lobe; and 5, honey-
combing (with or without septal thickening) 
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involving >75% of the lobe. The GGO score 
(GGS) was determined as follows: 0, no GGO; 1, 
GGO involving <5% of the lobe (minimal, but not 
normal); 2, GGO involving 5-25% of the lobe; 3, 
GGO involving 25-49% of the lobe; 4, GGO 
involving 50-75% of the lobe; and 5, GGO involv-
ing >75% of the lobe.
The degree of traction bronchiectasis or bron-
chiolectasis was quantified by assessing the 
level of the most proximal involved bronchial 
branches. The traction bronchiectasis score 
(TBS) was determined as follows [12]: 0, none; 
1, bronchial dilatation involving bronchi distal 
to the fifth generation; 2, bronchial dilatation 
involving fourth-generation bronchi; and 3, 
bronchial dilatation involving bronchi proximal 
to the third-generation bronchi.
After each section was scored individually, an 
average score of all sections of a single scan 
was obtained and used for statistical analysis. 
We also recorded other manifestations of the 
native lung, transplanted lung, and pleural 
space, such as consolidation, nodules, emphy-
sema, and pleural effusion.
CT lung volume measurement
We reconstructed the three-dimensional native 
lung and measured the volume of the native 
lung of each patient in the workstation (AW2, 
GE Healthcare), using the “Lung Volume” tool. 
We removed the volume of the threshold out-
side the scope of -2000 to 80 Hu, to obtain a 
three-dimensional representation of the native 
lungs and to assess their volume.
Statistical analysis
SPSS statistical software was used for the sta-
tistical analysis (SPSS v.13, SPSS Inc., Chicago, 
IL, USA). Pearson’s linear regression analysis 
was used to test the correlation between years 
since transplantation and fibrosis in the predic-
tion of IPF progression. A P-value <0.05 was 
considered statistically significant.
Results
Twelve patients (3 female, 9 male; age range: 
49-66 years, mean age: 58.6 years) met our 
selection criteria between Jan 2000 and Feb 
2012 and were entered into the study. Eight 
Figure 1. Progression of fibrosis on CT scans of the native lung of a 57-year-old male patient with IPF at (A) 11 
months, (B) 36 months, and (C) 75 months post-SLT.
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patients died during the study period. SLT was 
performed on the right side in six patients and 
on the left side in six patients. Thirty one CT 
had medial pleural effusions on their initial CT 
scans, and one had atelectasis in the grafted 
lung on their follow-up CT scan. Three patients 
Figure 2. Changes in the fibrosis score over time.
Figure 3. Changes in the traction bronchiectasis score over time.
Figure 4. Changes in the GGO score over time.
scans were evaluated. Initial CT ex- 
aminations were obtained a mean 
of 3.7 ± 1.9 months after SLT (range: 
7 months before to 11 months after 
SLT). The follow-up period after SLT 
ranged 43-110 months (mean: 74.7 
± 19.5 months). Two to five CT exam-
inations were performed in each 
patient.
Eleven patients showed an increase 
in the extent of fibrotic changes in 
the native lung after SLT (Figure 1). 
One patient remained stable at 36 
months post-SLT. The average FS 
increased with time since SLT (r= 
0.515, P<0.001). Average rate of FS 
progression on the CT scans was 
0.300/year (Figure 2). All patients 
showed progression in the TBS on 
later CT scans compared to the first 
scan, with a rate of progression 
of approximately 0.147/year (r= 
0.696, P<0.001; Figure 3). GGS 
decreased in seven patients, was 
stable in one patient, and worsened 
in four patients (Figure 4).
The native lung volume decreased in 
nine and increased in three patients 
in later CT scans compared to the 
initial CT images. The three patients 
with increased lung volume had 
moderate to large pleural effusions, 
which affected the native lung vol-
ume measurements from their infe-
rior CT scans. Therefore, the volume 
data for these three patients were 
excluded from the analysis. In nine 
patients, the native lung volume in 
lung CT reconstruction measure-
ments decreased over time (rate of 
decrease: 5.4%/year, r=0.653, P= 
0.001; Figure 5), Mean native lung 
volumes among all 12 patients at 
1, 3, 4, 5, 6, and 9 years after SLT 
were 1243.70, 1168.69, 1227.84, 
1084.52, 1275.12, and 860.59 ml, 
respectively.
Three patients had an increase in 
lung volume; two of these patients 
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had consolidations in the native lung on follow-
up CT scans. These consolidations were prima-
ry lung cancer (n=2) or bacterial infection (n=1). 
One patient had multiple small nodules that 
were diagnosed as an aspergillus infection. 
Three patients had pleural effusions and one 
patient had a pneumothorax. Two patients 
were diagnosed with emphysema on their first 
CT scan, and the affected area increased on 
follow-up CT images.
Discussion
IPF is a progressive disease with a very poor 
prognosis. To date, no large-scale randomized 
controlled trial has proven that pharmacologi-
cal treatments are effective for reducing pro-
gression of fibrosis. Lung transplantation is 
the only recognized treatment for IPF, and the 
improved three-component immunosuppres-
sant drug regimen has become generally 
accepted and widely used after transplanta-
tion. However, to our knowledge, no studies 
have evaluated IPF progression in the native 
lung under this regimen. CT scanning is a 
commonly used noninvasive imaging tool for 
evaluating lung fibrosis [12-16]. CT scoring is 
usually semi-quantitative, with low levels of 
inter observer variability when conducted by 
expert radiologists [5, 11, 17-20]. Several stud-
ies have proven the effectiveness of CT imag-
ing analysis for scoring the degree of fibrosis in 
IPF [5, 21].
Our results showed that the use of the com-
monly accepted immunosuppressive treatment 
regimen could not prevent further development 
of IPF in the native lung of patients after SLT. 
could affect the lung’s volume (e.g., pleural 
effusion). Similar to the findings of Elicker et al. 
[9], we observed a decrease in the GGO severi-
ty over time after SLT (n=10).
Certain limitations of our study need to be 
acknowledged. This was a retrospective review 
of patients evaluated at a single center, with all 
of the issues of selection and observational 
bias that this design carries. Secondly, although 
the sample size of our study was equivalent to 
or larger than that of prior studies, it still repre-
sents a small number of patients. Thirdly, the 
pulmonary functional test results from some 
patients were unavailable. Therefore, we could 
not test whether the CT lung volume correlated 
with these results. Additionally, we did not 
obtain our scans with reproducible respiratory 
gating. Lastly, the CT parameters used in this 
study were not uniform because of the long 
time period. Although we used the thinnest slic-
es possible to reconstruct some of the early 
data, the FS and GGS may reflect some uncon-
trolled variations.
In conclusion, our study found that in the native 
lung of patients treated with SLT for IPF, fibrosis 
worsened and lung volume decreased at a 
rate of approximately 6%/year from the time of 
transplantation.
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Figure 5. A negative linear correlation between the volume of the na-
tive lung and years since transplantation. SLV: single lung volume (na-
tive lung volume).
Evaluation of the CT images showed 
similar results to those of prior stud-
ies [7-9].
With our scoring system, the FS 
increased at a rate of 0.300/year. 
This result differs from that of Elicker 
et al. [9], who found an increase of 
11%/year. However, the Elicker et al. 
study included cases with follow-up 
times ranging from 6 months to 8 
years after SLT, whereas the follow-
up scans in the present study were 
obtained between 3 and 9 years 
after SLT. In the present study, 
the volume of the native lung de- 
creased by 6%/year in patients with-
out other complicating factors that 
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